• Home
  • Contact
  •  NL 
  • Login medewerkers
  • mijnUMCG

Future directions on the treatment of patients with Hodgkin Lymphoma

Print 
Datum: 27 februari 2019
Tijd: 17:30
Locatie: UMCG, lokaal 16, Onderwijscentrum
Adres: Hanzeplein 1, 9713 GZ Groningen

​​​​​​​​Noordelijke Refereeravond Radiotherapie

​​The department of Radiation Oncology is very pleased to invite you to the upcoming research meeting Noordelijke Refereeravond Radiotherapie​​

​Summary

Radiotherapy and systemic treatment are both cornerstones in the treatment of Hodgkin​ Lymphoma, resulting in high cure rates. ​Despite the developments over the last decades, late treatment-related complications, ​especially cardiac toxicity and secondary malignancies, are remaining side effects. 

Insight ​in the factors ​contributing to the development of these side effects is crucial to develop primary and secondary preventive strategies. Primary prevention in radiotherapy mainly focuses on reducing the radiation dose to organs at risk by new radiation technologies. Despite the introduction of new photon-based technologies, radiation dose to normal tissues still is substantial. 

At present, the national indication protocol for proton therapy is under development. During this research meeting, a number of experts in the field will discuss the limitations ​of current treatment of Hodgkin lymphoma and the potential advantages and challenges related to the introduction of proton therapy.​

Target group

Radiation oncologists, hematologists, residents, medical physicists and RTT’s.

​Chairman

Max Beijert​

​​Program


​Time​Subject
17.30 - 17.55

Welcome and registration. Sandwiches will be served at 17:30

17:55 - 18:00

Introduction

Max Beijert, MD, PhD, Radiation Oncologist, UMCG

18:00 - 18:30​

Cardiovascular toxicity after radiotherapy of Hodgkin Lymphoma patients​

Berthe Aleman, MD PhD, Radiation Oncologist, NKI-AVL

​18:30 - 19:00

Latest insights in the systemic treatment of Hodgkin lymphoma, how to be just as good with less toxicity? 

Wouter Plattel, MD, Hematologist, ​UMCG

19:00 - 19:20

Coffee Break

19:20 - 19:50

Challenges in the mediastinal lymphoma proton pencil beam scanning treatment, planning and delivery

Prof. Stefan Both, PhD, DABR, FAAPM, Head of Medical Physics, department of Radiation Oncology, UMCG​

​19:50 - 20:10

Paneldiscussie en dialoog onder leiding van Marian Verkerk

The near future, steps to be taken to treat patients with proton therapy

Anne Niezink, MD, Radiation Oncologist, UMCG

20:10

Closing drinks​

​ ​

Registration and further information

Please be aware that registration in advance is mandatory. Registration will be on the ‘first come, first serve’ basis. We kindly request you to registrate at: Contact.

Secretariat Radiation Oncology UMCG, telephone numer +31(0)50 361 55 32​.​